182 related articles for article (PubMed ID: 29170515)
21. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
22. LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray.
Liu WT; Lu X; Tang GH; Ren JJ; Liao WJ; Ge PL; Huang JF
World J Gastroenterol; 2014 May; 20(20):6314-21. PubMed ID: 24876753
[TBL] [Abstract][Full Text] [Related]
23. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC
J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNAs as biomarkers and therapeutic targets: Recent insights into hepatocellular carcinoma.
Qiu L; Tang Q; Li G; Chen K
Life Sci; 2017 Dec; 191():273-282. PubMed ID: 28987633
[TBL] [Abstract][Full Text] [Related]
25. Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.
Huang Z; Huang L; Shen S; Li J; Lu H; Mo W; Dang Y; Luo D; Chen G; Feng Z
Oncol Rep; 2015 Nov; 34(5):2403-12. PubMed ID: 26352013
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNAs: Novel insights into hepatocelluar carcinoma.
He Y; Meng XM; Huang C; Wu BM; Zhang L; Lv XW; Li J
Cancer Lett; 2014 Mar; 344(1):20-27. PubMed ID: 24183851
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of long non-coding RNA GAS5-AS1 and its prognostic and diagnostic significance in hepatocellular carcinoma.
Wang Y; Jing W; Ma W; Liang C; Chai H; Tu J
Cancer Biomark; 2018; 22(2):227-236. PubMed ID: 29660898
[TBL] [Abstract][Full Text] [Related]
28. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
[TBL] [Abstract][Full Text] [Related]
29. A MALAT1/HIF-2α feedback loop contributes to arsenite carcinogenesis.
Luo F; Sun B; Li H; Xu Y; Liu Y; Liu X; Lu L; Li J; Wang Q; Wei S; Shi L; Lu X; Liu Q; Zhang A
Oncotarget; 2016 Feb; 7(5):5769-87. PubMed ID: 26735578
[TBL] [Abstract][Full Text] [Related]
30. Metformin inhibits tumorigenesis in HBV-induced hepatocellular carcinoma by suppressing HULC overexpression caused by HBX.
Jiang Z; Liu H
J Cell Biochem; 2018 Jun; 119(6):4482-4495. PubMed ID: 29231260
[TBL] [Abstract][Full Text] [Related]
31. The long non-coding RNA MALAT1 promotes the migration and invasion of hepatocellular carcinoma by sponging miR-204 and releasing SIRT1.
Hou Z; Xu X; Zhou L; Fu X; Tao S; Zhou J; Tan D; Liu S
Tumour Biol; 2017 Jul; 39(7):1010428317718135. PubMed ID: 28720061
[TBL] [Abstract][Full Text] [Related]
32. Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma.
Konishi H; Ichikawa D; Yamamoto Y; Arita T; Shoda K; Hiramoto H; Hamada J; Itoh H; Fujita Y; Komatsu S; Shiozaki A; Ikoma H; Ochiai T; Otsuji E
Cancer Sci; 2016 Feb; 107(2):149-54. PubMed ID: 26614531
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.
Lai MC; Yang Z; Zhou L; Zhu QQ; Xie HY; Zhang F; Wu LM; Chen LM; Zheng SS
Med Oncol; 2012 Sep; 29(3):1810-6. PubMed ID: 21678027
[TBL] [Abstract][Full Text] [Related]
34. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
Ma Y; Luo T; Dong D; Wu X; Wang Y
Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
[TBL] [Abstract][Full Text] [Related]
35. The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis.
Wang BG; Lv Z; Ding HX; Fang XX; Wen J; Xu Q; Yuan Y
Gene; 2018 Sep; 670():148-154. PubMed ID: 29803923
[TBL] [Abstract][Full Text] [Related]
36. Up-regulation of long non-coding RNA Sox2ot promotes hepatocellular carcinoma cell metastasis and correlates with poor prognosis.
Shi XM; Teng F
Int J Clin Exp Pathol; 2015; 8(4):4008-14. PubMed ID: 26097588
[TBL] [Abstract][Full Text] [Related]
37. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
38. Invasion and metastasis-related long noncoding RNA expression profiles in hepatocellular carcinoma.
Gao Y; Chen G; Zeng Y; Zeng J; Lin M; Liu X; Liu J
Tumour Biol; 2015 Sep; 36(10):7409-22. PubMed ID: 25900874
[TBL] [Abstract][Full Text] [Related]
39. Small Nucleolar RNA Host Gene 18 Acts as a Tumor Suppressor and a Diagnostic Indicator in Hepatocellular Carcinoma.
Liu XF; Thin KZ; Ming XL; Shuo-Li ; Ping-Luo ; Man-Zhu ; Li ND; Tu JC
Technol Cancer Res Treat; 2018 Jan; 17():1533033818794494. PubMed ID: 30126319
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]